Fortress Biotech, Inc. (FBIOP) vs Nyxoah S.A. (NYXH)
A side-by-side comparison of Fortress Biotech, Inc. and Nyxoah S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FBIOP
Fortress Biotech, Inc.
$18.30HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
NYXH
Nyxoah S.A.
$1.42HealthcareDelayed quote: Oct 6, 2026, 3:36 PM EDT
Total return — FBIOP vs NYXH
growth of $100 · dividends reinvested · last 5yFBIOP +6.8% (+1.3%/yr)NYXH -94.1% (-43.3%/yr)FBIOP compounded faster over this window
Log scale — wide-divergence pair
FBIOP NYXH
FBIOP vs NYXH: by the numbers
- •FBIOP is the larger company ($144M vs $142M market cap).
- •FBIOP is profitable (163.32% net margin) while NYXH runs a net loss (-435.70%).
- •NYXH grew revenue faster over the past five years (120.68% vs 5.39% CAGR).
Metrics side by side
Valuation
| Metric | FBIOP | NYXH |
|---|---|---|
| P/E ratio | 6.82 | N/A |
| Forward P/E | 7.18 | N/A |
| P/S ratio | 2.10 | 5.42 |
| P/B ratio | 0.88 | 1.50 |
| FCF yield | 87.35% | N/A |
Profitability
| Metric | FBIOP | NYXH |
|---|---|---|
| Gross margin | 62.53% | 63.13% |
| Operating margin | -111.00% | -827.76% |
| Net margin | 163.32% | -435.70% |
| ROE | 68.12% | -120.33% |
| ROIC | -10.85% | -61.13% |
Growth (annualized)
| Metric | FBIOP | NYXH |
|---|---|---|
| Revenue CAGR (5Y) | 5.39% | 120.68% |
| Total return CAGR (5Y) | 0.05% | -45.84% |
Frequently asked
- Which has grown faster, FBIOP or NYXH?
- Over the past five years, NYXH grew revenue faster — FBIOP at a 5.39% CAGR versus NYXH at 120.68%.
- Is FBIOP or NYXH more profitable?
- FBIOP runs the higher net margin — FBIOP at 163.32% versus NYXH at -435.70%.
- How have FBIOP and NYXH total returns compared?
- Over the past 5 years, FBIOP delivered 0.05% and NYXH delivered -45.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Fortress Biotech P/E ratioFortress Biotech ROENyxoah ROEFortress Biotech operating marginNyxoah operating marginFortress Biotech revenue growthNyxoah revenue growthFortress Biotech free cash flowNyxoah free cash flow
Fortress Biotech & Nyxoah appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.